HCPCS Level IIdrugActive
J0517
Inj., benralizumab, 1 mg
BETOS: O1E
Effective: 2019-01-01
Description
Injection, benralizumab, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fasenra
Manufacturer
AstraZeneca Pharmaceuticals LP
HCPCS Dosage
1 MG
Billing Units
30.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.